Patients in whom PCI is preferred over CABG _ Aleksander Ernst Clinical Hospital Center Zagreb University of Zagreb School of Medicine Zagreb, CROATIA

Similar documents
What do the guidelines say?

Unprotected LM intervention

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

Management of cardiovascular disease - coronary interventions -

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Adults With Diagnosed Diabetes

PCI vs. CABG From BARI to Syntax, Is The Game Over?

Cindy L. Grines MD FACC FSCAI

Δημήτριος Αγγοσράς, FETCS

EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017

Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?

Left Main Intervention: Where are we in 2015?

Le# Main Interven-on: When Is It Appropriate. Femi Philip, MD Assistant Professor Of Medicine UC Davis

Emergency surgery in acute coronary syndrome

FAME STUDY: 2-year Follow-Up & CLINICAL SUBGROUP ANALYSIS

Controversies in Cardiac Surgery

VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators

The MAIN-COMPARE Study

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France

Surgery Grand Rounds

Rationale for Percutaneous Revascularization ESC 2011

Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents

Southern Thoracic Surgical Association CABG in 2012: Implications of the New ESC/EACTS Guidelines

Left Main PCI vs. CABG: Real World

Diabetic Patients: Current Evidence of Revascularization

Reconciling the Results of the Randomized Trials

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing

CABG vs PCI: What do the Guidelines Say?

PROMUS Element Experience In AMC

How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting

DECLARATION OF CONFLICT OF INTEREST

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

LM stenting - Cypher

Mise à Jour sur le traitement du Pluritronculaire Philippe Généreux, MD

INDIVIDUALIZED MEDICINE

Approach to Multi Vessel disease with STEMI

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction

Percutaneous coronary intervention in patients with multi-vessel coronary artery disease: a focus on physiology

Long-term outcomes of PCI vs. CABG for ostial/midshaft lesions in unprotected left main coronary artery

ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΣΤΟ ΔΙΑΒΗΤΙΚΟ ΑΣΘΕΝΗ

SYNTAX III REVOLUTION Trial Press briefing conference. Prof. Patrick W. Serruys MD, PhD Principal Investigator Imperial College of London

Coronary Artery Disease: Revascularization (Teacher s Guide)

Coronary interventions

Treatment Options for Angina

Subsequent management and therapies

Revascularization In HFrEF: Are We Close To The Truth. Ali Almasood

Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011

Medical Rx vs PCI vs CABG

Cardiac catheterisation in nonagenarians: Single center experience

Supplement materials:

Early discharge in selected patients after an acute coronary syndrome can it be safe?

Ischemic Heart Disease Interventional Treatment

STEMI AND MULTIVESSEL CORONARY DISEASE

Supplementary Online Content

Abciximab plus Heparin versus Bivalirudin in Patients with NSTEMI Undergoing PCI. ISAR-REACT 4 Trial

SAHA PCI or CABG for Left Main and Multi-Vessel Disease: when I would definitely/ maybe/never refer my patient for PCI or CABG

CABG for ischemic cardiomyopathy, post myocardial infarction and cardiogenic shock

STEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology

FFR in Multivessel Disease

Rationale for Left Ventricular Support During Percutaneous Coronary Intervention

Management of Cardiogenic shock. Prof. Christian JM Vrints

Supplementary Online Content

Left Main Intervention: Will it become standard of care?

COURAGE to Leave Diseased Arteries Alone

Cardiogenic Shock. Carlos Cafri,, MD

Rationale for Prophylactic Support During Percutaneous Coronary Intervention

'Coronary artery bypass grafting in patients with acute coronary syndromes: perioperative strategies to improve outcome'

Ischemic Heart Disease Interventional Treatment

FFR Incorporating & Expanding it s use in Clinical Practice

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

CLINICAL CONSEQUENCES OF THE

10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice

Controversies in Cardiac Pharmacology

presenters 2010 Sameh Sabet Ain Shams University

Supplementary Material to Mayer et al. A comparative cohort study on personalised

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.

HREVS: A Randomized Trial of PCI vs CABG vs Hybrid Revascularization in Patients With Coronary Artery Disease. Vladimir Ganyukov, MD, PhD

The top 5 trials in the last year: Ischemic Heart Disease

Joo-Yong Hahn, MD/PhD

Update interventional Cardiology Hans Rickli St.Gallen

Role of echocardiography in the assessment of ischemic heart disease 분당서울대학교병원윤연이

Alex versus Xience Registry Preliminary report

The MAIN-COMPARE Registry

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

Perspective of LM stenting with Current registry and Randomized Clinical Data

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016

SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS?

Adecade ago, many cardiac surgeons believed

Sudden death as co-morbidity in patients following vascular intervention

The American College of Cardiology/American Heart

That unprotected LM: To STENT or NOT to STENT. Vasilios Papademetriou, MD Professor of Medicine Georgetown University

Dave Kettles, St Dominics Hospital East London.

CPORT E Trial. Atlantic C PORT

Transcription:

3rd Dubrovnik Cardiology Highlights An ESC Update Programme in Cardiology 26.09.-29.09.2013, Hotel Excelsior, Dubrovnik, Croatia Patients in whom PCI is preferred over CABG _ Aleksander Ernst Clinical Hospital Center Zagreb University of Zagreb School of Medicine Zagreb, CROATIA

Potential conflicts of interest Speaker's name: Aleksander Ernst I do not have any potential conflict of interest

ESC/EACTS Guidelines European Heart Journal (2010) 31, 2501 2555 Recommend ations for reperfusion strategies in ST-segment elevation myocardial infarction patients

- STEMI

Recommendations for percutaneous coronary intervention in ST-segment elevation myocardial infarction ESC/EACTS Guidelines European Heart Journal (2010) 31, 2501 2555

ESC/EACTS Guidelines European Heart Journal (2010) 31, 2501 2555 Specific recommend ations for diabetic patients

Recommendations for patients with chronic heart failure and systolic left ventricular dysfunction (ejection fraction 35%), presenting predominantly with anginal symptoms ESC/EACTS Guidelines European Heart Journal (2010) 31, 2501 2555

Crossed revascularization procedures ESC/EACTS Guidelines European Heart Journal (2010) 31, 2501 2555

- NSTEMI

Unresolved issues: HOW PCI MATCHES CABG IN LMCA LESIONS MULTIVESSEL CORONARY ARTERY DISEASE MULTIVESSEL CAD IN DIABETICS?

GLOBAL RISC CLASSIFICATION

MACCE to 5 years by Syntax Score Tercile Left Main Disease PCI or CABG PCI or CABG CABG

d d

Figure 4. Adverse events in patients treated with DES for distal LMCA disease (DLMCAD) compared with patients treated for nondistal LMCA disease (NDLMCAD). Smith C R Circulation 2009;119:1013-1020 Copyright American Heart Association

All end-points in favour of CABG

Figure 6. The 95% CI for Ln (adjusted hazard ratio) of CABG patient death and percutaneous transluminal coronary angioplasty (PTCA) patient death within a 3-year period (excluding patients with MI <24 hours before procedure). Smith C. Circulation 2009;119:1013-1020 Copyright American Heart Association

Impact of Revascularization on Mortality in Diabetic Patients with Multivessel Disease - MASS II Trial Soares, Circulation 2006

PCI vs. CABG in Diabetes FREEDOM: 1900 pts with diabetes + MVD Randomized to SES/PES vs CABG Primary Endpoint: Death, Stroke, or MI

Freedom - Myocardial Infarction

Freedom All cause of death

Freedom Stroke

Freedom Repeat Revascularitation

Freedom MACCE (death,stroke,mi,repeat revascularization)

- NSTEMI

Real life data From: Coronary Revascularization Trends in the United States, 2001-2008 JAMA. 2011;305(17):1769-1776. doi:10.1001/jama.2011.551 Figure Legend: Date of download: 9/22/2013 Copyright 2012 American Medical Association. All rights reserved.

Real life data PCI CABG Heart Disease and Stroke Statistics--2012 Update Circulation. 2012;125:e2-e220

Real world data The annual rate of revascularization decreased significantly, but by only 15% (p<0.001). The CABG rate decreased significantly, by nearly 40%, from 1742 surgeries per million adults per year to 1081 (p<0.001). PCI rates did not change significantly (from 3827 procedures per million adults per year to 3667 procedures, p=0.74). The number of hospitals that provide CABG increased, resulting in a 28% decrease in the median CABG caseload per hospital. The results, write the authors, suggest the possibility that several thousand patients who underwent PCI in 2008 would have undergone CABG surgery had patterns of care not changed markedly between 2001 and 2008. Our data imply a sizeable shift in cardiovascular clinical practice patterns away from surgical treatment toward percutaneous, catheterbased interventions. (JAMA. 2011;305[17]1769-1776.)

Emerging new Scoring Systems Anatomical (2)» Syntax score» LMCA Clinical (6)» Age» CrCl» LV EF» Sex» COPD» PVD

Syntax score II PCI CABG CABG 40.0» 4y mortality 15.1% 27 11 PCI - 35.0» 4y mortality 9.8% Age 75

CONCLUSIONS PCI PREFERRED IN 1. STEMI 2. NSTEMI (CULPRIT LESION only) 3. NSTEMI W. CARDIOGENIC SHOCK MV PCI) 4. LMCA (OSTIUM, SHAFT) + 1 VD 5. EARLY GRAFT FAILURE AFTER CABG 6. LATE GRAFT FAILURE AFTER CABG

CONCLUSIONS PCI OR CABG TO BE DISCUSSED BY HEART TEAM 1. STEMI 2. NSTEMI MVD EXCEPT CULPRIT LESION 3. DISTAL LMCA 4. MVD DISEASE GRC <32 5. MVD IN DIABETICS GRC <32

CONCLUSIONS CABG remains standard of care for more complex disease and diabetics 1. LMCA DISTAL (BIFURCATION)+MVD 2. MVD WITH GRC>33 3. MVD IN DIABETICS<32

PATIENT INFORMATION & CONSENT

MY PERSONAL VIEW UNFAVOURABLE ANATOMY IS THE ONLY REASON FOR NOT PERFORMING PCI IN THE DES ERA: feasibility = indication feasibilty = ability to perform the complex procedure safely at a reasonable and acceptable risk

Ethic of reciprocity Golden Rule Do not unto others what you would not have others do to you! This is the whole law; the rest, merely commentaries upon it! Rabbi Hillel Hannasi, The Babylonian, 110 BC 10 AD, Talmud